HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Impact of Early Life Antibiotic Exposure and Neonatal Hyperoxia on the Murine Microbiome and Lung Injury.

Abstract
Cross talk between the intestinal microbiome and the lung and its role in lung health remains unknown. Perinatal exposure to antibiotics disrupts the neonatal microbiome and may have an impact on the preterm lung. We hypothesized that perinatal antibiotic exposure leads to long-term intestinal dysbiosis and increased alveolar simplification in a murine hyperoxia model. Pregnant C57BL/6 wild type dams and neonatal mice were treated with antibiotics before and/or immediately after delivery. Control mice received phosphate-buffered saline (PBS). Neonatal mice were exposed to 95% oxygen for 4 days or room air. Microbiome analysis was performed using 16S rRNA gene sequencing. Pulmonary alveolarization and vascularization were analyzed at postnatal day (PND) 21. Perinatal antibiotic exposure modified intestinal beta diversity but not alpha diversity in neonatal mice. Neonatal hyperoxia exposure altered intestinal beta diversity and relative abundance of commensal bacteria in antibiotic treated mice. Hyperoxia disrupted pulmonary alveolarization and vascularization at PND 21; however, there were no differences in the degree of lung injury in antibiotic treated mice compared to vehicle treated controls. Our study suggests that exposure to both hyperoxia and antibiotics early in life may cause long-term alterations in the intestinal microbiome, but intestinal dysbiosis may not significantly influence neonatal hyperoxic lung injury.
AuthorsMelissa H Althouse, Christopher Stewart, Weiwu Jiang, Bhagavatula Moorthy, Krithika Lingappan
JournalScientific reports (Sci Rep) Vol. 9 Issue 1 Pg. 14992 (10 18 2019) ISSN: 2045-2322 [Electronic] England
PMID31628395 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Bacterial Agents
  • RNA, Ribosomal, 16S
  • Ampicillin
Topics
  • Ampicillin (adverse effects, pharmacology)
  • Animals
  • Animals, Newborn (microbiology)
  • Anti-Bacterial Agents (adverse effects, pharmacology)
  • Bronchopulmonary Dysplasia (etiology)
  • Disease Models, Animal
  • Dysbiosis (chemically induced)
  • Female
  • Gastrointestinal Microbiome (drug effects, genetics)
  • Hyperoxia (complications)
  • Mice
  • Mice, Inbred C57BL
  • Pregnancy
  • Pulmonary Alveoli (pathology)
  • RNA, Ribosomal, 16S (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: